This inventor holds 2 USPTO granted patents. Top assignees: Mayo Foundation for Medical Education and Research, University of Illinois. Active years: 2020-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2020-2023
Title: Richard Martin Graybill: Innovator in Microfluidic Technology
Introduction
Richard Martin Graybill is a notable inventor based in Urbana, IL (US). He has made significant contributions to the field of microfluidics, particularly through his innovative patents. With a total of 2 patents, Graybill's work has the potential to advance various applications in biological research and medical technology.
Latest Patents
Graybill's latest patents focus on chromatin immunocapture devices and methods of use. These applications provide fluidic devices, such as microfluidic devices, which can be utilized for the creation and manipulation of droplets in droplet-based microfluidic systems. The microfluidic devices can generate droplets, extract or inject volume to droplets, and split droplets. Additionally, the patents include methods for generating nucleosomes and isolating DNA from nucleosomes or non-nucleosomes using the disclosed devices.
Career Highlights
Throughout his career, Richard Martin Graybill has worked with esteemed organizations such as the University of Illinois and the Mayo Foundation for Medical Education and Research. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of Graybill's notable coworkers include Steven R Doonan and Tamas Ordog. Their collaborative efforts have further enhanced the development of innovative technologies in microfluidics.
Conclusion
Richard Martin Graybill's contributions to microfluidic technology through his patents and collaborations highlight his role as an influential inventor in the field. His work continues to pave the way for advancements in biological and medical applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile